The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 15 of the 47 sources its claims cite were checked for support.
Towards a vaccine against pregnancy-associated malaria
Open accessAbstract
Review on vaccine development against pregnancy-associated malaria, including VAR2CSA, placental sequestration on chondroitin sulfate A, anaemia, and adverse outcomes.
Overview
CoChat Summary
TL;DR
This review argues that pregnancy-associated malaria is driven by placental sequestration of *P. falciparum*–infected erythrocytes via CSA, and that VAR2CSA is the leading vaccine target because antibodies against it are associated with protection. It also emphasizes that a VAR2CSA-based vaccine remains challenging because of polymorphism, unclear epitope targets, and the possibility of additional ligands or mechanisms.
Key findings
- Pregnancy-associated malaria is linked to maternal anaemia, reduced birth weight, and increased infant morbidity/mortality; placental malaria is said to carry a two-fold increased risk of low-birth-weight delivery, with the greatest effect in primigravidae.
- The paper states that VAR2CSA, the PfEMP1 encoded by var2csa, is the main VSA involved in pregnancy-associated malaria, and that it contains six DBL domains, with at least four able to bind CSA.
- Evidence cited in the paper indicates that antibodies against VAR2CSA/CSA-adhesion are associated with protection: levels of antibodies inhibiting adhesion to CSA correlated inversely with susceptibility to preterm delivery and low birthweight, and VAR2CSA-specific IgG correlated with maternal haemoglobin and infant birthweight.
- The authors note major barriers to a vaccine: multiple var2csa alleles were found in field isolates, several VAR2CSA domains bind CSA, and human antibodies preferentially target polymorphic rather than conserved regions.
Methods
- Not stated in the paper.
- This is a review article synthesizing prior field, immunological, and molecular studies on pregnancy-associated malaria and malaria vaccine development.
- The analysis is narrative: it compares published evidence on placental sequestration, naturally acquired immunity, VAR2CSA, and vaccine challenges.
Limitations
- The paper explicitly states that significant challenges still exist for developing a VAR2CSA-based vaccine with profound efficacy, including sequence polymorphism and uncertainty about how many variants to include.
- It also states that additional targets and protective immune mechanisms could well exist, and that evidence for CSA binding may involve multiple ligands or a multiprotein complex, not only VAR2CSA.
- Evident from the text: this is a non-systematic narrative review, so it does not present new primary data, a predefined search strategy, or quantitative meta-analysis of vaccine efficacy.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 21 Not checked · 8 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“but analysis of var2csa from field isolates has revealed alternating areas of substantial interclonal polymorphism (Dahlback et al. , 2006; Trimnell et al. , 2006).”
What the sources say
- Supportedcites Dahlback et al., 2006 source
The Results/Discussion section reports an alignment of VAR2CSA DBL3X sequences from placental parasite isolates. It identifies four relatively conserved regions separated by three shorter variable regions, supporting the claim about alternating regions of interclonal variation within the analyzed portion of var2csa. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites Trimnell et al., 2006 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Naturallyacquired immunity to malaria observed at adulthood in those areas is largely due to the acquisition of IgG with specificity for a repertoire of parasite-encoded VSA expressed on the surface of iEs (Nielsen et al. , 2002).”
What the sources say
- Partly supportedcites Nielsen et al., 2002 sourceExperimental — accuracy not yet measured
The Abstract says protection develops through childhood and correlates with antibodies to a broad repertoire of VSA on infected erythrocytes. The Discussion describes an important protective role for VSA-specific antibodies, but qualifies that role as potentially only partial. The paper does not establish that IgG to VSA is largely responsible for immunity observed in adults; its reported IgG analysis concerns children. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C SA has been consistently identified as the dominant placental adhesion receptor (Beeson et al. , 1999; Fried & Duffy, 1996).”
What the sources say
- Supportedcites Beeson et al., 1999 source
The Results (Cytoadherence to purified receptors) show that CSA binding was much more common among placental isolates than binding to CD36 or ICAM-1. The Discussion reports that most placental isolates adhered to CSA and describes an earlier placental-isolate study with the same pattern. The paper also notes exceptions, so “dominant” does not mean universal. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites Fried & Duffy, 1996 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent study identified a ~ 22 KDa protein, but no protein within the PfEMP1 molecular weight range, as a ligand for CSA (Gowda et al. , 2007).”
What the sources say
- Partly supportedcites Gowda et al., 2007 sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports that a C4S photoaffinity probe labeled a ~22-kDa parasite protein rather than a protein in the 200–400-kDa PfEMP1 range. But the photoaffinity-labeling section says the protein may either bind C4S directly or be part of an adhesive complex; calling it an identified ligand overstates that result. The Discussion also does not exclude PfEMP1 from such a complex. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although var2csa is structurally conserved between P. falciparum isolates and is consistently over-expresssed by placental isolates (Duffy et al. , 2006; Tuikue Ndam et al. , 2005), multiple var2csa alleles were found in field isolates (Dahlback et al. , 2006).”
What the sources say
- Supportedcites Dahlback et al., 2006 source
The Results/Discussion section reports sequence polymorphisms in var2csa and an alignment of 43 DBL3X sequences from Senegalese placental isolates. This supports the claim that multiple var2csa variants were found in field isolates. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
19 more claims · 3 with their cited sources checked
Create a free account to see all 44 claims and every source verdict.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1002/14651858.cd000129 · retracted 2003-01-20 · notice 10.1002/14651858.cd000129.pub2 · this paper published 2008-09
Citations
Cites
1 retracted
Vaccines for preventing malaria
Graves, P. M., & Gelband, H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000129 · Cited by 63
RetractedThe pathogenic basis of malaria
Miller, L. H., Baruch, D. I., Marsh, K., & Doumbo, O. K. (2002) · Nature · doi:10.1038/415673a · Cited by 1,746
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005
Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei
NUSSENZWEIG, R. S., VANDERBERG, J., MOST, H., & ORTON, C. (1967) · Nature · doi:10.1038/216160a0 · Cited by 937
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Maternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Stevenson, M. M., & Riley, E. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1311 · Cited by 653
Research works printed but not linked: 1
- GAMAIN B. Identification of multiple CSA binding domains in the var2csa gene transcribed in CSA binding parasites. J. Infect. Dis. , 2005, 191 (6), 1010-1013.
Cited by
Huynh, B.-T., Fievet, N., Gbaguidi, G., Dechavanne, S., Borgella, S., Guézo-Mévo, B., Massougbodji, A., Ndam, N. T., Deloron, P., & Cot, M. (2011) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.11-0103 · Cited by 124
Self-citationSander, A. F., Salanti, A., Lavstsen, T., Nielsen, M. A., Magistrado-Coxen, P., Lusingu, J., Ndam, N. T., & Arnot, D. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006667 · Cited by 75
Self-citationBuckee, C. O., & Recker, M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002451 · Cited by 43
Breman, J. G. (2009) · Science Progress · doi:10.3184/003685009x440290 · Cited by 49
Bordbar, B., Ndam, N. T., Bigey, P., Doritchamou, J., Scherman, D., & Deloron, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.065 · Cited by 43
Self-citation
Metadata
- Authors
- Tuikue Ndam, N., & Deloron, P.
- Affiliations
- Institut de Recherche pour le Développement (FR)
- ORCID
- Deloron, P.
- Venue
- Parasite
- Publisher
- EDP Sciences
- Published
- 2008-09
- Volume
- 15
- Issue
- 3
- Pages
- 515-521
- ISSN
- 1252-607X (ISSN-L)
- 1776-1042
- OpenAlex
- W2019789231
- Cited by
- 14
- References
- 62
- Citations by year
- 2020: 1 · 2019: 1 · 2017: 2 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Parasite (publishedVersion)
- PubMed (publishedVersion)
- Springer Link (Chiba Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission (200889)
- Agence Nationale de la Recherche (009-01, ANR-05)
- Institut de Médecine et d'Epidémiologie Appliquée
- CHIST-ERA
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- malaria in pregnancy, Plasmodium falciparum, VAR2CSA, PfEMP1, chondroitin sulfate A, placental sequestration, vaccine development, variant surface antigens, placental malaria, anemia in pregnancy, infant morbidity and mortality
- MeSH terms
- Animals, Antigens, Protozoan, Erythrocytes, Female, Humans, Plasmodium falciparum, Pregnancy, Pregnancy Complications, Parasitic, Malaria, Falciparum, Malaria Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Towards a vaccine against pregnancy-associated malaria. https://app.cochat.ai/papers/10.1051/parasite/2008153515
- The paper
- Tuikue Ndam, N., & Deloron, P. (2008). Towards a vaccine against pregnancy-associated malaria. Parasite. https://doi.org/10.1051/parasite/2008153515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.